April 25, 2019
The Medicines Company Reports First-Quarter 2019 Financial Results and Significant Progress with the Inclisiran Clinical Development Program
Inclisiran’s unique profile, vast global market opportunity and long-dated exclusivity set the stage for potentially significant shareholder value creation Independent…